EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Bioorganic and Medicinal Chemistry Letters

Description
a Tetrahedron publication for rapid dissemination of preliminary communications on all aspects of bioorganic chemistry, medicinal chemistry and related disciplines

 

Status
active
Indexing
Adis LMS Drug Alerts; BIOSIS; Beilstein Database;
Biochemistry and Biophysics Citation Index; CAB Abstracts; CAB Health; Cancerlit; Chemical Abstracts; Chemical Citation Index; Current Contents/Life Sciences; EMBASE; Elsevier BIOBASE/Current Advances in Biological Sciences;
Excerpta Medica; MEDLINE®; Pascal; Research Alert;
SCISEARCH; Science Citation Index; Scopus; TOXFILE
Subject

Source type
Journal
Publisher
ISBN ISSN
0960-894X
First volume
1
Last volume
23+
Homepage
Description
Bioorganic & Medicinal Chemistry Letters presents preliminary experimental or theoretical research results of outstanding significance and timeliness on all aspects of science at the interface of chemistry and biology and on major advances in drug design and development. The journal publishes articles in the form of communications reporting experimental or theoretical results of special interest, and strives to provide maximum dissemination to a large, international audience.


Related links:









Imprint     Disclaimer

© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )